Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer C Price

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Gastroenterology & Hepatology|February 26, 2024
Preventative Hepatology and the Reduction of All-Cause Mortality in Liver DiseaseJennifer C Price
JAMA Internal Medicine|March 3, 2020
Updated Hepatitis C Virus Screening Recommendation-A Step ForwardJennifer C Price, Danielle Brandman
Alimentary Pharmacology & Therapeutics|January 29, 2020
Editorial: HBV-the promise of a new era in therapeuticsJennifer C Price, Debika Bhattacharya
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 21, 2010
Liver disease in the HIV-infected individualJennifer C Price, Chloe L Thio
Current Opinion in Gastroenterology|April 14, 2025
Update on hepatitis C virus managementAustin D Peer, Jennifer C Price
Clinical Liver Disease|June 14, 2024
A framework for approaching hepatitis C reinfection in people who use drugsRebecca G Kim, Jennifer C Price
Hepatology (Baltimore, Md.)|April 20, 2017
ReplyJennifer C Price, Phyllis C Tien
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 22, 2015
Treatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos inJennifer C Price, Norah A Terrault
The American Journal of Gastroenterology|October 6, 2017
Editorial: Statins and Liver Disease: Is it Time to Recommend Statins to Prevent Liver Disease Progression?Jennifer C Price, Phyllis C Tien
Liver International : Official Journal of the International Association for the Study of the Liver|September 4, 2014
Sofosbuvir and ribavirin use in wait-listed patients with hepatitis C should be selectiveJennifer C Price, Norah A Terrault
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Gastroenterology & Hepatology|February 26, 2024
Preventative Hepatology and the Reduction of All-Cause Mortality in Liver DiseaseJennifer C Price
JAMA Internal Medicine|March 3, 2020
Updated Hepatitis C Virus Screening Recommendation-A Step ForwardJennifer C Price, Danielle Brandman
Alimentary Pharmacology & Therapeutics|January 29, 2020
Editorial: HBV-the promise of a new era in therapeuticsJennifer C Price, Debika Bhattacharya
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 21, 2010
Liver disease in the HIV-infected individualJennifer C Price, Chloe L Thio
Current Opinion in Gastroenterology|April 14, 2025
Update on hepatitis C virus managementAustin D Peer, Jennifer C Price
Clinical Liver Disease|June 14, 2024
A framework for approaching hepatitis C reinfection in people who use drugsRebecca G Kim, Jennifer C Price
Hepatology (Baltimore, Md.)|April 20, 2017
ReplyJennifer C Price, Phyllis C Tien
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 22, 2015
Treatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos inJennifer C Price, Norah A Terrault
The American Journal of Gastroenterology|October 6, 2017
Editorial: Statins and Liver Disease: Is it Time to Recommend Statins to Prevent Liver Disease Progression?Jennifer C Price, Phyllis C Tien
Liver International : Official Journal of the International Association for the Study of the Liver|September 4, 2014
Sofosbuvir and ribavirin use in wait-listed patients with hepatitis C should be selectiveJennifer C Price, Norah A Terrault
Pageof 10